Eaton Vance Management’s Moderna MRNA Stock Holding History

Eaton Vance Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$57.3M	Sell	484,689 -461	-0.1%	-$70K	0.09%	228
2022 Q2	$69.3M	Buy	485,150 +15,271	+3%	+$2.18M	0.1%	211
2022 Q1	$80.9M	Buy	469,879 +45,715	+11%	+$7.7M	0.09%	211
2021 Q4	$108M	Sell	424,164 -3,361	-0.8%	-$983K	0.13%	153
2021 Q3	$163M	Buy	427,525 +47,649	+13%	+$17.6M	0.23%	97
2021 Q2	$89.3M	Sell	379,876 -1,211	-0.3%	-$216K	0.12%	178
2021 Q1	$49.9M	Buy	381,087 +373,539	+4,949%	+$54.1M	0.07%	264
2020 Q4	$789K	Buy	+7,548	New	+$764K	﹤0.01%	1138

Other funds holding MRNA

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Eaton Vance Management's MRNA Position: Q3 2022 in Review

Eaton Vance Management reduced its Moderna (MRNA) stake by 0.1% in Q3 2022, selling an estimated $70K and leaving 484,689 shares worth $57.3M. The position accounts for 0.09% of the portfolio, ranked #228.

Eaton Vance Management first reported a position in MRNA in Q4 2020 and has held it in 8 quarters since. The position peaked at $163M in Q3 2021. 915 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

Eaton Vance Management held 484,689 shares of Moderna worth $57.3M as of Q3 2022.
Eaton Vance Management sold 461 Moderna shares in Q3 2022, an estimated $70K.
Moderna made up 0.09% of Eaton Vance Management's portfolio in Q3 2022, its #228 holding.
Eaton Vance Management first reported a position in Moderna in Q4 2020 and has held it in 8 quarters since.
Eaton Vance Management's Moderna position peaked at $163M in Q3 2021.
915 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on Eaton Vance Management's 13F filing for Q3 2022, filed 14 Nov 2022.